Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...
Healthcare investors spooked by recent headlines on cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth Group Inc.'s billing practices are worrying about the wrong thing.
ORLADEYO net revenue of $124.2 million for Q4 2024 (+36.6 percent y-o-y) and $437.7 million for FY 2024 (+34.3 percent y-o-y)——FY 2025 ORLADEYO ...
Musk caused alarm among federal employees over an email sent on Saturday requesting that employees summarize their work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results